ATE35506T1 - Selektive methode zum blockieren von 5ht2 rezeptoren. - Google Patents

Selektive methode zum blockieren von 5ht2 rezeptoren.

Info

Publication number
ATE35506T1
ATE35506T1 AT84301586T AT84301586T ATE35506T1 AT E35506 T1 ATE35506 T1 AT E35506T1 AT 84301586 T AT84301586 T AT 84301586T AT 84301586 T AT84301586 T AT 84301586T AT E35506 T1 ATE35506 T1 AT E35506T1
Authority
AT
Austria
Prior art keywords
receptors
blocking
selective method
dihydroxyalkyl
hydroxyalkyl
Prior art date
Application number
AT84301586T
Other languages
English (en)
Inventor
Marlene Lois Cohen
Ray Ward Fuller
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE35506T1 publication Critical patent/ATE35506T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • Prostheses (AREA)
  • Holo Graphy (AREA)
  • Eye Examination Apparatus (AREA)
AT84301586T 1983-03-10 1984-03-09 Selektive methode zum blockieren von 5ht2 rezeptoren. ATE35506T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/473,882 US4563461A (en) 1983-03-10 1983-03-10 Selective method for blocking 5HT2 receptors
EP84301586A EP0122044B1 (de) 1983-03-10 1984-03-09 Selektive Methode zum Blockieren von 5HT2 Rezeptoren

Publications (1)

Publication Number Publication Date
ATE35506T1 true ATE35506T1 (de) 1988-07-15

Family

ID=23881404

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84301586T ATE35506T1 (de) 1983-03-10 1984-03-09 Selektive methode zum blockieren von 5ht2 rezeptoren.

Country Status (6)

Country Link
US (1) US4563461A (de)
EP (1) EP0122044B1 (de)
JP (1) JPS59175431A (de)
AT (1) ATE35506T1 (de)
DE (2) DE3408730A1 (de)
IT (1) IT1209512B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
AU594373B2 (en) * 1985-10-01 1990-03-08 Eli Lilly And Company Esters of dihydrolysergic acid
US4906639A (en) * 1985-10-01 1990-03-06 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid
US4762842A (en) * 1985-10-01 1988-08-09 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4939258A (en) * 1985-10-01 1990-07-03 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid
US4968802A (en) * 1985-10-01 1990-11-06 Eli Lilly And Company Process of making alkoxy cycloalkanol esters of dihydrolysergic acid
US4845224A (en) * 1985-10-01 1989-07-04 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonist properties
US4847261A (en) * 1985-10-01 1989-07-11 Eli Lilly And Company Alkoxy cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonists properties
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
US4683236A (en) * 1985-10-01 1987-07-28 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid useful as 5Ht2 receptor antagonists
US4713385A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Alkoxy and dialkoxyalkyl esters of dihydrolysergic acid and related compounds useful as 5HT receptor antagonists
US4820713A (en) * 1985-10-01 1989-04-11 Eli Lilly And Company Ketoalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US4714704A (en) * 1985-10-01 1987-12-22 Eli Lilly And Company Alkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US4810710A (en) * 1985-10-01 1989-03-07 Eli Lilly And Company 4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraine
US4713384A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4704395A (en) * 1985-12-20 1987-11-03 Eli Lilly And Company Cyclic ether esters of 2-substituted-6-(substituted and unsubstituted) dihydrolysergic acid useful as 5HT receptor antagonists
US4704396A (en) * 1985-12-20 1987-11-03 Eli Lilly And Company Phenacyl esters of 1-substituted-6-(substituted and unsubstituted) dihydrolysergic acids useful as 5HT receptor antagonists
EP0228876A3 (de) * 1985-12-20 1989-03-22 Eli Lilly And Company Ester von Dihydrolysergsäure und verwandte Verbindungen
US4683237A (en) * 1985-12-20 1987-07-28 Eli Lilly And Company Fluoroalkyl esters of dihydrolysergic acid useful as 5HT2 receptor antagonists
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
US5688807A (en) * 1994-03-11 1997-11-18 Eli Lilly And Company Method for treating 5HT2B receptor related conditions
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249617A (en) * 1966-05-03 Alkylated d-lyserglc acid
US3228941A (en) * 1966-01-11 Methyl and i,g-dimethyl-ergoline i derivatives
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
US3580916A (en) * 1969-02-20 1971-05-25 Lilly Co Eli Hydroxyesters of hexa- and octahydroindoloquinolines
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
GB1290203A (de) * 1970-09-01 1972-09-20
BE792515A (fr) * 1971-12-10 1973-06-08 Sandoz Sa Nouveaux derives de l'acide lysergique, leur preparation et leur application comme medicaments
JPS5443649B2 (de) * 1973-06-05 1979-12-21
US4153700A (en) * 1975-08-27 1979-05-08 Lake Shore Roentgenology Ltd. Treatment of the acute after-effects resulting from alcohol ingestion
YU40004B (en) * 1977-07-21 1985-06-30 Lek Tovarna Farmacevtskih Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Also Published As

Publication number Publication date
IT8419995A0 (it) 1984-03-09
EP0122044A1 (de) 1984-10-17
JPS59175431A (ja) 1984-10-04
IT1209512B (it) 1989-08-30
EP0122044B1 (de) 1988-07-06
US4563461A (en) 1986-01-07
DE3408730A1 (de) 1984-09-13
DE3472529D1 (en) 1988-08-11

Similar Documents

Publication Publication Date Title
ATE35506T1 (de) Selektive methode zum blockieren von 5ht2 rezeptoren.
BG60249B2 (en) Thiazole compound for treatment of ulcers
DK0640592T3 (da) N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister
KR930703311A (ko) 물질 p의 길항제인 n-알킬 퀴누클리디늄염
MX9504349A (es) Derivados de aroilpiperidina.
ATE31307T1 (de) Benzofuran- und benzopyrancarboxamid-derivate.
IT1171880B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
DK577584A (da) Substituerede 2-pyridylmethyl-thio og -sulfinylbenzimidazoler til brug som gastriske antisekretoriske midler
ES2111930T3 (es) Antagonistas del acido amp y procedimientos de tratamiento con la ayuda de estos.
DE3360904D1 (de) A fungicidal indanylbenzamide
CU34216A (es) Derivados de dibenzofurano
DK422183A (da) Fremgangsmaade til fremstilling af 5-halogenvinyl-2'-deoxyuridinderivater
ES521440A0 (es) Un procedimiento para preparar derivados de imidazolina.
DK156396C (da) 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse
ATE45575T1 (de) Prostacycline.
JPS5293771A (en) Benzotriazoles
NO914074D0 (no) Polyvinylkloridsammensetninger med forbedret bearbeidelses stabilite
SE8700566L (sv) Tetracykliska kinazolinoner
DE3362723D1 (en) Pyrido-triazoloquinazolines, their preparation and use
ES442327A1 (es) Procedimiento para la preparacion de nuevos compuestos de hidrodipiranoftalazina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee